Somewhat frustrated by this management making excuse after excuse for poor performance. We all have to deal with cost and operational challenges. Seems like they struggle to adapt. On top of that they made a simple grammar mistake i.e., affects vs effects. FFS!
With that out of the way, on balance, it looks good. As with most market cycles, I expect earnings to improve significantly over the next couple of years. The company seem more conservative with leverage and capex at this point in time.
MRM Price at posting:
39.0¢ Sentiment: Buy Disclosure: Held
